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Objetive: investigate in the literature ways of developing occupational diseases in the professional 
category of pharmaceuticals-biochemical and the strategies used for prevention occupational injuries and 
illnesses among these health professionals. Method: it is an integrative literature review, which search 
strategies was by consultation in Lilacs, Pubmed (Medline), ISI Web of Knowledge and Scopus databases, 
during the period of 1986 to 2010 and the following key-words were selected: accidents, occupational; 
chemical contamination; occupational health; control and prevention; accident prevention; disease 
prevention; health personnel; pharmaceutics and biochemical. Results: a total of eight articles were 
selected and classified according their level of evidence. The mutagenic risk, caused by the handling of 
chemotherapeutic agents, was the most frequently risk reported. Conclusion: some reports of 
occupational cancer and cytogenetic alterations were have been reported, but further investigations are 
necessary to prove the real cause. Descriptors: pharmacists, occupational risks, occupational accidents, 
occupational health. 
 
 
Objetivo: investigar na literatura as formas de adoecimento pelo trabalho na categoria profissional dos 
farmacêuticos e bioquímicos causados pela exposição a agentes químicos e as estratégias utilizadas para 
prevenção de adoecimentos e acidentes de trabalho entre esses profissionais. Método: trata-se de uma 
revisão integrativa da literatura, realizada nas bases de dados eletrônicas Lilacs, Pubmed (Medline), ISI 
Web of Knowledge e Scopus, no período de 1986 a 2010, utilizando os descritores e palavras-chave: 
acidentes de trabalho; contaminação química; saúde do trabalhador; prevenção e controle; prevenção de 
acidentes; prevenção de doenças; pessoal da saúde; farmacêuticos e bioquímicos. Resultados: um total de 
oito artigos foram selecionados e classificados segundo o nível de evidência. O risco mutagênico, 
ocasionado pela manipulação de quimioterápicos, foi relatado com maior frequência. Conclusão: alguns 
casos de câncer ocupacional e alterações citogenéticas foram descritos, porém sugere-se maior 
investigação para comprovação da causa. Descritores: farmacêuticos, riscos ocupacionais, acidentes de 
trabalho, saúde do trabalhador. 
 
 
 
Objetivo: investigar, en la literatura, las formas de enfermedades causadas por el trabajo en la categoría 
profesional de los farmacéuticos y bioquímicos y las estrategias utilizadas para la prevención de lesiones y 
accidentes do trabajo relacionados a estos profesionales. Método: el estudio se trata de una revisión 
integradora de la literatura, cuya estrategia de búsqueda fue por consulta a las bases de datos 
electrónicas, en el período de 1986 hasta 2010 en las bases de datos  Lilacs, Pubmed (Medline), ISI Web of 
Knowledge y Scopus. Los seguintes descriptores fuerón utilizados: accidentes de trabajo; contaminación 
química; salud laboral; prevención de accidentes; prevención de enfermidades; personal de salud; 
farmacéuticos e bioquímicos. Resultados: un total de ocho artículos fueron seleccionados y clasificados 
según el nivel de evidencia. El riesgo mutagénico, causado por la manipulación de agentes 
quimioterápicos, fue relatado con la mayor frecuencia. Conclusión: algunos casos de cáncer profesional y 
alteraciones citogenéticas han sido descritos, pero se sugiere más investigaciones para probar la causa. 
Descriptores: farmacéuticos, riesgos laborales, accidentes de trabajo, salud laboral. 
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he theoretical framework of Worker Health has as its object of 
study the health-disease processes of human groups in their relationship to the job, seeking 
the understanding of how and why these processes occur. As well as the development of 
alternative forms of intervention, that will lead to their transformation.1 Actuation in 
health promotion has as its fundamental objective the appreciation of the human being in 
its totality, contributing to the reduction of accidents and diseases related to labor.2 
The occupational risks originate from unhealthy or dangerous situations, defined as 
all conditions or factors existing in the work environment that may generate damage to 
workers' health and are classified into: physical, chemical, biological, ergonomic and psyco-
social.3 
The regulatory Standard No. 09 (NR 9) considers as chemical agent substances, 
compounds or products that can penetrate the organism by the respiratory route (dust, 
smoke, haze, fog, gasses or vapors) or that may have contact or may be absorbed by the 
body through the skin or by ingestion.4 
The physical damage related to chemical exposure include irritation from skin and 
eyes, minor burns, up to poisoning and toxicity.  In a general way, chemical substances are 
introduced in the area of health in its various states, such as gasses, vapors and liquids for 
use in sterilization, disinfection of materials, anesthetics and drug treatments for patients 
like, for instance, chemotherapy.5 
In the hospital, when exposure to antineoplastic agents occurs without the proper 
follow-up of appropriate safety recommendations, workers may be exposed to the risk of 
contact and/or absorption of chemical agents whilst carrying out activities. This includes 
manipulation of antineoplastic agents, preparation of doses to be administered, 
administration of the medication to the patient and contact with excretions of the patient 
in treatment interruption.  
Scientific evidence shows that professionals in the hospital area with 
greater involvement in such activities are the area of nursing and pharmacy. In addition, 
other groups are also exposed, even that is not acting in a hospital environment, as for 
example, the individuals who work in pharmaceutical industries, the cleaning staff and the 
researchers.6 
In relation to professional pharmacists-biochemists, with the growth of the 
profession and the great diversity of tasks performed, these professionals are subject to risk 
factors of physical, chemical, biological and ergonomic nature when performing their of its 
activities, in addition to the risks of organizational and psychosocial nature.7 
A bibliographic study8 revealed that great attention should be given to the sector of 
pharmacy and radio-pharmacy, due to excessive workload, failures in the use of Personal 
INTRODUCTION 
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METHOD 
Protection Equipment (PPE), budgetary constraints and professional burnout identified by 
surveys carried out with professionals of this area. 
Research carried out with the objective to verify the occurrence of work-related 
accidents in the biennium 2002-2003 through the assessment of 570 health professionals 
practicing in public hospitals in the Federal District, showed an index of 17.6% of accidents 
with biological material in the category of pharmacists-biochemists.9  However, there is 
little scientific evidence suggesting work-related accidents and illness within this 
occupational category through contamination by chemical agents.  
With this in mind, this study was conceived to answer the following research 
questions:  
- What are the causes of work-related accidents and illnesses of pharmaceutics and 
biochemists, caused by exposure to chemical risk? 
- What are the proposed interventions for prevention of illnesses by working with this 
professional category?  
Thus, the present study has to investigate in national and international literature the 
accidents and illnesses caused by exposure to chemicals in pharmacists and biochemists 
and the strategies used to prevent them. 
 
 
 
 
 
 
TYPE OF STUDY 
The methodology adopted was the integrative review of literature that together with 
the systematic review composes the method of Practice Based on Evidence.10 
The integrative review enables the understanding of a given phenomenon by means 
of knowledge on it, which leads to the identification of gaps yet to be investigated.11  
 
DEVELOPMENT OF THE RESEARCH STRATEGY 
The following stages were observed, as recommended by the literature: 1 - 
establishment of the research question; 2 - search strategies (establishments of inclusion 
and exclusion criteria, data base and selection of studies); 3 - categorization of studies 
(extraction, organization and summarization of data); 4 - assessment of studies included in 
the review; 5 - interpretation of results and 6 - synthesis of knowledge.10 
The following descriptors and key words in Health Science (DeCS) were selected: 
accidents at work, chemical contamination, worker health, prevention and control, 
accident prevention, prevention of diseases, personal health, pharmacists and 
biochemists. Two authors of this research have worked independently in order to identify 
those descriptors and key words and cross them separately and in combination in the 
following databases: Lilacs, Medline Pubmed (), ISI Web of Knowledge and Scopus. 
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RESULTS AND DISCUSSION 
DEFINITION OF INCLUSION AND EXCLUSION CRITERIA 
Articles on quantitative or qualitative methodology, on work-related accidents 
and diseases caused by exposure to chemical hazards among pharmaceutical and 
biochemical workers and the strategies for prevention of same; published in Portuguese, 
English and Spanish languages from 1986 thru 2010, available in the selected databases. The 
exclusion criteria was the unavailability of articles in their entirety. 
With respect to the classification of the selected articles, classification of evidence 
level12 was followed in order to compose a sample of studies. This classification is shown in 
Figure 1. 
Evidence 
Level 
Description 
1 
Systematic Review (RS) or meta-analysis of all Randomized Controlled 
Trials (RCT) or relevant clinical guidelines based on RS of RCT 
2 At least one RCT well delineated 
3 Well-designed clinical Trials without randomization 
4 Case-control Studies and cohort well delineated 
5 RS of descriptive studies or qualitative 
6 Single study descriptive and qualitative 
7 Opinion of authorities and/or report of committees of experts 
Figure 1 - System of evidence classification, as to hierarchical levels of quality12. 
 
 
 
 
 
 
 
 
 
 The search in the databases delivered the following number of studies: 
Lilacs (1097); Medline (601); Scopus (965) and Isi Web of knowledge (536), totaling 3199 
studies to be reviewed. After the exclusion of duplicates, 675 articles remained to be 
analyzed.         
Many studies were excluded after reading the summaries, seeing that they would not 
meet the criteria for inclusion. Some studies that showed relevant summaries were, 
however, excluded after complete reading by the authors of the research for not addressing 
the exposure to chemical hazards or for relating to other professional categories. Other 
studies were excluded because they were not in accordance with the methodological 
criteria of classification level of clarity.12 After rigorous analysis of the studies, the final 
sample subsisted of eight articles.  
The presentation and discussion of the results and conclusions were performed in a 
descriptive way, seeking answers to the questions raised initially. Among the studies 
included in the sample, three (37.5 %) were of descriptive methodology, three studies (37.5 
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%) were experimental and one (12.5 %) retrospective cohort study. The type of methodology 
and the level of evidence of the studies are described in Figure 2. 
 
N Authors The Study Design 
Evidence 
Level 
1 Gregoire, Segal, Hale13 Descriptive-analytical study 6 
2 Arrington14 Descriptive study 6 
3 McDevitt, Lees, McDiarmid15 Descriptive-analytical study 6 
4 
Edling, Mr Friis, Mikoczy, Hagmar, 
Lindfors16 
Retrospective cohort study, 4 
5 Welch, Deffenbaugh17 
Opinion of authorities and 
reports of committee of 
experts 
7 
6 
Hessel, Radon, Pethran, Maisch, 
Gröbmair, Sautter18 
Experimental study, non-
randomized 
3 
7 
Schreiber, Radon, Pethran, Schierl, 
Hauff, Grimm et al. 
Experimental study, 
randomized 
4 
8 
Tanimura, Yamada, Sugiura, Mori, 
Nagatta, Tadokoro et al. 
Experimental study, non-
randomized  
3 
Figure 2 - Presentation of the synthesis of articles included in the integrative review, 
according to the design of the study and classification of the level of clarity12. 
  
The studies brought the topic of factors of chemical risks through exposure to agents 
present in neoplastic and antineoplastic chemotherapy drugs, and its main findings are 
represented in Figure 3. 
 
Authors 
Periodical 
Publication 
Topics Covered Main findings 
Gregoire, 
Segal, Hale13 
American 
Journal of 
Hospital 
Pharmacy 
Exposure to 
chemotherapeutic 
agents and 
preventive 
strategies 
Approximately 94% of the 
institutions used the Cab of 
Biological Safety and workers 
considered the need to join the 
majority of EPI. Some preventive 
strategies were cited. 
Arrington14 
American 
Journal of 
Hospital 
Pharmacy 
Exposure to 
chemotherapeutic 
agents and 
preventive 
strategies 
Implementation of strategies for 
reducing exposure to 
chemotherapeutic agents, as to the 
multidisciplinary, training and 
continuing education. 
McDevitt, 
Lees, McDiar
mid15 
Journal of 
Occupational 
and 
Environmental 
Medicine 
Exposure to 
chemotherapeutic 
agents 
The analysis of samples of air and 
surfaces in a pharmacy and 
an oncology clinic indicated 
contamination by 
cyclophosphamide. 
Edling, Mr 
Friis, 
Mikoczy, 
Hagmar, 
Lindfors16 
Scandinavian 
Journal of 
Work, 
Environment & 
Health 
Exposure to 
chemotherapeutic 
agents 
Identification of cases of cancer 
among the workers that have been 
manipulating chemotherapeutic 
agents, but the causality was not 
proven. 
Welch, 
Deffenbaugh
American 
Journal of 
Health System 
Exposure to 
chemotherapeutic 
agents and 
The authors' opinions converge to 
the need for the constant presence 
of a pharmacist responsible during 
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17 Pharmacy. preventive 
strategies 
the handling of drugs. 
Hessel, 
Radon, 
Pethran, 
Maisch, 
Gröbmair, 
Sautter18 
Nem Research: 
Genetic 
Toxicology and 
environmental 
mutagenesis 
Exposure to 
chemotherapeutic 
agents 
The findings of possible genotoxicity  
of professionals handling 
chemotherapeutic agents were not 
proven. 
Schreiber, 
Radon, 
Pethran, 
Schierl, 
Hauff, 
Grimm et al. 
International 
Archives of 
Occupational 
and 
Environmental 
Health 
Exposure to 
chemotherapeutic 
agents 
The analysis of the urine of workers 
for the presence of 
cyclophosphamide was proven. 
Tanimura, 
Yamada, 
Sugiura, 
Mori, 
Nagatta, 
Tadokoro et 
al. 
Journal of 
Health Science 
Exposure to 
chemotherapeutic 
agents 
The analysis of the urine of workers 
for the presence of 
cyclophosphamide was proven. 
Figure 3 - Presentation of the synthesis of articles included in the integrative review, 
according the approached risk and the main results. 
 
The sample of studies confirms the occurrence of work-related accidents with 
exposure to chemotherapeutic agents, but it is not conclusive as to the causation of 
occupational diseases and diseases related to such exposure. Some studies have confirmed 
the presence of biological changes in workers due to exposure to chemical hazards, such as 
the presence of the excretion of the drug in the urine in excess quantities, thus showing the 
urgent need for interventions of corrective and preventive character.    
  
 Although the findings are not conclusively indicating causality of diseases generated 
by occupational contamination through the manipulation of various chemotherapeutic 
agents, the results suggest that the implementation of security measures directed to all 
workers, in a multi-disciplinary character, may reduce exposure and possible contamination 
of workers. 
The articles selected for the sample composition treat chemical risks, in particular 
the carcinogenic, teratogenic and mutagenic risks originating from exposure 
to chemotherapy drugs. 
The literature reveals that among the various types of occupational hazards to which 
workers in the area of health care are exposed, chemical risks represent exposure to agents 
and chemical substances common in work processes, among them: dust, smoke, haze, fog, 
gasses, vapors, substances, compounds or chemical products in geral.3 Among the activities 
of handling these substances, is the preparation and administration of medications that, if 
not carried out correctly, can cause from allergic reactions up to neoplasias.2 
The adverse effects of exposure to chemotherapeutic agents were in 1993 still 
proposed as a potential problem for occupationally exposed populations.15 The authors 
evaluated exposure to antineoplastic agents through analysis of samples of 
cyclophosphamide (an alkylating compound classified as a carcinogenic, mutagenic and 
teratogenic human and animal), present in the air and on the surface of objects in a 
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pharmacy and oncology clinic of a university hospital, where the safety standards of the 
Occupational Safety and Health Administration (OSHA) were implemented.2 
The results of the study mentioned above, included in this sample, 15 found rare air 
samples with detection of drugs, but several samples of surfaces showed measurable 
concentrations of cyclophosphamide, indicating that the staff of the pharmacy can be 
exposed even with the use of the Cab of Biosafety (CSB).  These results bring implications 
for healthcare professionals who handle antineoplastic and, according to the authors, show 
several situations that allow the occurrence of exposure by digestive and epidermal ways. 
Chemotherapy drugs are used in the treatment of some diseases, one of which 
is cancer. In this case, they destroy the tumor cells, and so are classified as oncogenic. For 
this reason, the handling of this type of medication, without strict 
observation of appropriate standards and security procedures recommended, can lead to 
numerous toxic effects to the worker that handles them.6 
One of the studies analyzed 16 verified exposures to antineoplastic agents by means 
of the evaluation of the cancer cases in workers of a pharmaceutical company in Sweden. 
The findings identified 72 cases of incidence of cancer in this population. This number is 
lower than the rates of incidence of cancer expected, 74 cases, for the Swedish population 
in general. This study identified four cases of acute leukemia and eight cases of 
urogenital cancer by the workers of the company. These indices were considered 
significant, but it was reported that this finding cannot be related to any specific chemical 
exposure, due to other causal factors intrinsic to the development of a cancer. 
Literature findings indicate that a study of bibliographic review conducted with 
nursing workers, showed that these workers had chronic damage possibly originated from 
exposure to antineoplastic agents (liver damage and nasopharyngeal carcinoma).  In that 
study it was highlighted that intravenous drugs, including chemotherapy, in past decades 
were prepared without the proper adherence of workers to the standard precautions. It was 
however concluded that in none of the cases reported, the causal relationship managed to 
be firmly established, there is the possibility that, in the majority of cases, the causal 
relationship is only speculation.23 
Due to the risk of accidents and occupational diseases originating from exposure to 
antineoplastic agents, the adverse effects of exposure to chemotherapeutic agents have 
been studied and the risk of exposure and contamination among health workers is a 
reality. Among these workers, pharmacists, responsible for preparation of drugs, present a 
higher risk to exposure to chemotherapeutic agents than nurses, who handle and administer 
the same.24 According to the author of this study, the effect of chemotherapy is considered 
desirable in patients in treatment, but are not acceptable when they occur as a result of an 
occupational exposure.  
The risks of chemotherapeutic agents for the long-term health are less well known, 
but some authors16,24 reported occurrences of chronic effects, such as: reproductive 
problems, abnormalities of chromosomes and cancer development in pharmacists, but the 
specific causality towards the manipulation of antineoplastic and loop diuretic still needs 
further study.23  
Some authors 23-4 reported that the chemical exposure to antineoplastic agents is a 
problem for the health, and even in small quantities can cause damage to the exposed 
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worker. The excretion of cyclophosphamide was found in technical professionals 
(pharmacists, nursing technicians and nurses) who manipulated chemotherapeutic agents 
and in some cases, the detection of drugs was also present in the urine of those who do not 
directly manipulate.23 These workers reported symptoms, such as skin irritation, sore 
throat, cough, malaise, headache, allergic reactions, diarrhea, nausea and vomiting.24 
Contamination of the environment can result in contamination of workers not 
involved in handling. This fact was observed in an experimental study present in the studied 
sample19, carried out with samples of urine 24 hours earlier harvested from 87 technicians 
of pharmacy and pharmacists from 14 hospitals in Germany to investigate the presence 
of antineoplastic agents, aiming to verify the influence of different working conditions 
observed during the preparation of cytostatic drugs. The results showed at least one 
positive result of urine for cytostatic agents in 56 (64 %) participants in the sample, while 32 
(37 %) workers presented more than one cytostatic agent in their urine.   
 The authors of the study concluded that both the workers who act as assistants 
during the preparation of antineoplastic agents as those who work directly in the 
preparation of them, did not show differences in relation to the frequency of exposure to 
cytostatic drugs. The same was observed with the workers who alternate the two 
functions and it was suggested that both were included for review and implementation of 
protective measures and disposal of the recommended safety precautions. 
The work conditions were also verified in this study, defining them as: tasks 
performed and the different forms of execution; conditions of cleaning up the environment; 
disposal of cytostatic agents; number of preparations; quantity of substances handled and 
the use of gloves (considering the type of material, thickness and interval).  The conclusion 
was that the absorption of antineoplastic agents happens during work routine and that the 
increase in the number of preparations carried out can lead to an increased exposure to 
workers who work in preparation and administration of chemotherapeutic agents. 7, 19 
A study conducted in Japan and selected to compose the sample20, evaluated the 
level of cyclophosphamide present in 24-hour urine of pharmacists who prepare 
chemotherapeutic agents. The drug was detected in urine samples of pharmacists, even 
with the use of security measures and protection to the worker. However, after further 
review and implementation of the measures of safety precautions related to the 
manipulation of chemotherapeutic agents, a decrease of the presence of the drug was 
observed, although the authors report that this difference is not statistically significant. 
Findings in the literature are convergent with the reduction of exposure of workers 
after the implementation of the measures of occupational safety. It was concluded that 
there was a reduction of cytogenetic alterations in health care workers after the imposition 
of specific measures of security, such as the use of protective equipment for workers' safety 
and compliance with the recommendations of guidelines.23 
An experimental study, included in the sample18, aimed at examining the frequency 
of genotoxicity induced by chemotherapeutic agents in a sample of 247 workers of 
pharmacy and nursing by means of blood collection and used a control group with 60 
workers in offices, who had no exposure to such medicines. Among the results, the authors 
identified that there were no significant differences in the analysis of the frequency of 
toxicity caused by exposure to cytostatic agents in exposed individuals and that the 
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comparison of the frequency of genotoxicity by time of occupational exposure not suggested 
an time-dependent accumulation for mutagenic effects. 
Another study included to compose this review aimed to assess the practices of 
manipulation of chemotherapeutic agents in cancer treatment centers and check the 
attitudes of workers involved in the handling of these drugs. Thus, a survey was carried 
out involving four categories: use of PPE and Collective Protection Equipment (EPC); 
practice of workers; policies and institutional procedures for security and observation of 
possible spills and disposal of the medicines.13  
Among the results of this study, the researchers found that more than 94% of the 
institutions used cab of biosafety (CSB).  The majority of workers considered the use of 
gloves and disposable static jackets of great importance, as with raincoats with closed 
sleeves, but denied the importance of using footwear and balaclavas. In addition, it was 
found that the absence of specific tests for the assessment of the concentration of exposure 
of workers during the preparation of chemotherapeutic agents, as well as the limits of 
exposure, and the rest periods were defined for only 6% of workers. 
Available literature shows that some chemicals can cause side effects to health 
professionals that handle them. For this reason, they must be handled in CSB, used as 
primary containment in working with agents of biological and/or chemical risk. The CSB are 
able to minimize the exposure of the operator, the product and the environment and should 
be used in conjunction with the EPI.25 
In a study carried out in Brazil with 30 nurses who manipulated and administrated 
chemotherapeutic agents in a university hospital, it was found that 40% had no information 
on the purpose and use of a laminar flow; 56,70% claimed to have knowledge, and 3.30% did 
not respond. The study found, by means of workers reports, the occurrence of work-related 
accidents with dermal exposure to antineoplastic agents in 16.7% of the professionals, 
which occurred during the dilution of these agents26. In this study, the professionals who 
participated did not follow the recommendations of the Brazilian Ministry of Health 27-8 and 
OSHA.29 
The standards recommended by OSHA, concerning the handling of antineoplastic 
agents, determine the  required PPE for handling of chemotherapeutic agents: the use of 
gloves (long, disposable, not pinched, manufactured with latex or polypropylene, with a 
thickness between 1.8 to 2.3 mm or the use of two pairs of these); aprons with closed front, 
long sleeves, cuffs with elastic bands and disposable; masks with protection of activated 
charcoal; goggles, caps and footwear. As collective protection equipment (EPC), it 
establishes the use of chapel of vertical laminar flow class II, type B. 20.29 
In relation to the strategies used for the prevention of illness and accidents at work, 
the studies presented some methods to control exposure, such as biological and 
environmental monitoring and the awareness and training of work teams in order to improve 
compliance with the recommendations of existing security. 
Among the strategies of prevention mentioned in the analyzed studies the transfer of 
pregnant women or mothers in breastfeeding for sectors with less exposure to various risks 
was presented as a follow-up of standard precautions and development of policies for legal 
counseling to workers in some cancer treatment centers. Regarding the method of 
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chemotherapy waste disposal, was cited the incineration of the same as the method most 
used by the majority of treatment studied centers.13 
Another included study14 developed in a university institution, taking as a reference 
the first guideline22 for safe handling of antineoplastic agents, showed the importance of 
the implementation of strategies aimed at the reduction of exposure to chemotherapeutic 
agents, highlighting the development of a multidisciplinary program for safety in the 
handling of chemotherapeutic agents. The communication with the team of 
pharmacists, considering the adoption of implementations of the program and the need 
for awareness of workers with respect to adherence to safety recommendations, 
contributed significantly to the realization of the project. Among other actions, the above 
study has deployed a training program for workers who deal with antineoplastic every two 
years and the maintenance of a process of continuing education with all workers. 
The literature refers to the recommendations of occupational safety published in 
guidelines   not being followed properly, although the fulfilment of standards has 
progressed since the release of the guidelines by OSHA22, 29 when the health 
institutions have established policies for the follow-up to the precepts of security. The 
awareness of the potential risks of exposure is not universal and the implementation of the 
recommendations of these guidelines is not complete and should be exploited. Due to the 
risk of contamination by aerosols, the masks with filter N-95 respiratory protection must be 
used, in particular, during the exchange of gloves used in the preparation of 
medications. Devices with closed systems in locations where there is preparation of 
chemotherapy must be implemented.23 
In Brazil, researchers analyze the problems related to the exposure of workers to 
chemical agents, stating that the implementation of the activities of workers still occurs in 
precarious conditions, without regard to the safety and hygiene of the work, and without 
guarantees of a decent work. For these authors these problems are not recent, but are 
growing, due to the availability of new substances and the growth in their use, only 
continues.30 
Study on the views of authorities, chosen to compose the present sample regarding 
the issue of exposure to chemical hazards resulting from chemotherapy, points out that 
their manipulation can bring serious and fatal consequences to patients, health care teams 
and the community. A preventive strategy to the occurrence of accidents at work would be 
the constant presence of a pharmacist during the manipulation of these drugs, conducting 
the assessment, the coordination, preparation, administration and the correct 
disposal thereof.17 
Thus, from the analysis of preventive strategies, aiming to reduce the exposure of 
pharmacists to antineoplastic agents, it was observed that the planning and 
implementation of security measures can be effective in reducing contamination of 
workers. Simple measures like as the standard precautions and planning and 
implementation of multidisciplinary programs aiming at the prevention of accidents and 
better communication between the team, have achieved good results. However, it can be 
inferred, by means of the analysis of the studies included, that the implementation of 
security measures is an ongoing process based on periodic training, continuing education, 
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permanent updates and constant evaluations, with views to the prevention and control of 
diseases present in occupational environment. 
 
 
 
 
 
 
With regard to the findings of the studies, in a general way, the tests of 
environmental and biological monitoring cited were not conclusive relating to the illness of 
workers exposed to antineoplastic agents, but many have found the real contamination by 
chemotherapeutic agents who directly or indirectly deal with these substances. In this way, 
it is suggested that further studies be carried out to ensure that the causality of 
occupational diseases due to exposure to chemotherapeutic agents can be proven.  
The results mark the absence of national Brazilian literature in the sample of studies 
included in this integrative review, which highlights gaps in Brazilian scientific production.  
The evidence presented herein are an advancing scientific knowledge in the area of 
worker health and corroboration of strategies in health that are planned in a preventative 
character. The results also reported that the follow-up of standard precautions by 
professionals and the attention directed at the prevention of work-related accidents and 
illness on the part of health institutions contribute to the reduction of exposure to the risks 
inherent in the work processes and lead to the promotion of the health of workers. 
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